NEW ORLEANS, Aug. 25, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2017 to file lead plaintiff applications in a securities class action lawsuit against Forterra, Inc. (Nasdaq:FRTA), if they purchased the Company’s shares pursuant to Forterra’s October 21, 2016 initial public offering (“IPO”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Forterra investors should visit us at https://www.claimsfiler.com/cases/view-forterra-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Forterra and certain of its executives are charged with failing to disclose material information during the IPO, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) there were substantial decreases in sales in certain products; (ii) Forterra was lowering prices in certain segments due to competition and softness in the market; (iii) defective products and long delays from production problems resulted in lost business and late charges; (iv) undisclosed material weaknesses in internal controls prevented accurate reporting and forecasting of financial results; and (v) as a result of the foregoing, Forterra’s Registration Statement was materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



